Symposiums

Biosimilars have contributed substantially to the evolving therapeutic landscape for inflammatory bowel disease (IBD), enabling healthcare systems to…

Prof Taylor opened the meeting and briefly highlighted the epidemiology of pregnancy in women with chronic rheumatic diseases. Dr Moltó presented the…

Prof Reich welcomed delegates to the satellite symposium and explained that the aims of the meeting were to introduce the clinical role of targeted…

Registries provide very high-quality data on the persistence of different therapies in the real world and can be used to compare and guide therapeutic…

The satellite symposium comprised two short presentations aimed at providing an overview of the rationale for the use of interleukin (IL)-23 inhibition…

Do flares of ulcerative colitis (UC) cause long-term bowel damage? Dr Sandborn opened the symposium by challenging the audience to think about their…

Given the progressive nature of Crohn’s disease (CD), Prof Panés made a case for timely intervention in at-risk patients to achieve the ultimate goal of…

The objective of this symposium was to provide an overview of the challenges in T2DM treatment and to discuss novel strategies that may overcome real-…